Pharmaresearch Showcases Aesthetic Portfolio at 53rd DAEPIMO Conference

Pharmaresearch, a specialized company in regenerative medicine, recently participated in the "53rd DAEPIIMO Busan Conference" held at Signiel Busan on the 30th of last month, showcasing its aesthetic portfolio including Rejuran® and Rejuviel®.

The DAEPIIMO, officially known as the Korean Society for Laser, Dermatology, and Hair Research, is one of the most prestigious academic organizations in the field of dermatology and aesthetic medicine in South Korea. The Busan conference attracted approximately 1,000 medical professionals from Busan, Ulsan, and the Gyeongnam region, sharing the latest insights and academic information in aesthetic medicine.

Pharmaresearch participated as a Gold Sponsor at the conference, setting up a large event room with 12 booths and conducting a variety of on-site promotional activities.

Notably, as part of the conference program, Pharmaresearch held an "Industrial Symposium" session focusing on its main aesthetic portfolio, including Rejuran®, Rejuviel®, and Evercle®, which garnered a positive response from attendees.

The symposium was divided into three lectures that delved into the unique technological capabilities and clinical efficacy of each product, as well as practical treatment know-how applicable in clinical settings, addressing the high academic needs of the local medical community.

A representative from Pharmaresearch stated, "It is significant to convey the excellence of our core aesthetic lineup to a large gathering of medical professionals from the Busan, Ulsan, and Gyeongnam regions at the DAEPIIMO conference. We will continue to expand academic exchanges at major locations nationwide, strengthening partnerships with medical professionals."